Double the shock, double the success? new trial tests dual cardioversion for AFib

NCT ID NCT07560644

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This clinical trial tests whether giving two electrical shocks at once (dual shock) is better than the standard single shock for restoring normal heart rhythm in people with persistent atrial fibrillation. About 177 participants will be randomly assigned to receive either a standard 200-joule shock or a dual 400-joule shock. The study will measure how many people return to normal rhythm after the first shock and track any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
electrical cardioversion (dual shock technique)
What this could lead to
If successful, this could provide a more effective way to restore normal heart rhythm in people with persistent atrial fibrillation, reducing the need for repeated procedures.
What could go wrong
This is a mid-stage trial with only 177 participants, so results may not apply to everyone. The dual shock carries a small risk of complications like skin burns or arrhythmias.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.